We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Accuri and eBIOSCIENCE Partner to Offer Complete Flow Cytometry Solutions

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Accuri Cytometers, Inc. and eBioscience announced that they have entered into a worldwide co-marketing agreement.

The collaboration is designed to offer scientists a better and more comprehensive solution for their flow cytometry research needs, harnessing ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with extensive line of high quality cytometer research reagents offered by eBioscience.

Explicitly designed for routine use by biomedical researchers in their own labs, Accuri’s full-featured bench-top cell analysis system provides capabilities similar to flow cytometers in a user-friendly format and at a fraction of the cost. eBioscience, which is among the largest suppliers of flow cytometry research reagents worldwide, offers a wide range of high quality flow cytometry research reagents optimized for a variety of applications.

Accuri designed the C6 system from the ground up with input from hundreds of researchers. Accuri's innovations, coupled with its components, resulted in a cytometer that is robust, compact, easy-to-use and affordable, at less than one-third the price of current flow cytometers and one-tenth the operating costs of the market leaders over five years of ownership, the companies say.

Further terms of the agreement were not disclosed.